SPONSOR
Ophthalmic Consultants of Long Island
Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: Patient Preference
Ophthalmic Consultants of Long Island is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Patient Preference.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ophthalmic Consultants of Long Island
How many clinical trials has Ophthalmic Consultants of Long Island sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Ophthalmic Consultants of Long Island, of which 1 are actively recruiting participants. These trials cover conditions including Patient Preference. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ophthalmic Consultants of Long Island research focus on?
Ophthalmic Consultants of Long Island clinical trials span Patient Preference. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ophthalmic Consultants of Long Island clinical trial?
To participate in a Ophthalmic Consultants of Long Island trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ophthalmic Consultants of Long Island trials with current recruitment status updated daily.
Clinical Trials by Ophthalmic Consultants of Long Island
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology